EUVIMEDEUVIMED entdecken
EditorialKommentar

Intensive Glucose Control in Critically Ill Patients — How Low Do We Go?

Shohinee Sarma

NEJM Evidence · 2024

DOI: 10.1056/evide2400196 ↗

Kurz gefasst

Editorial in der Zeitschrift NEJM Evidence, 2024. Verfasst von Shohinee Sarma. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston. Hauptthemen laut MEDLINE: Critical Illness, Blood Glucose. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessBlood GlucoseHumansHyperglycemiaCritical CareGlycemic ControlHypoglycemic AgentsIntensive Care UnitsInsulin

Substanzen

Blood GlucoseHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston.

Zitieren

APA

Sarma, S. (2024). Intensive Glucose Control in Critically Ill Patients — How Low Do We Go?. NEJM Evidence. https://doi.org/10.1056/evide2400196

Vancouver

Sarma S. Intensive Glucose Control in Critically Ill Patients — How Low Do We Go?. NEJM Evidence. 2024. doi:10.1056/evide2400196

BibTeX
@article{Sarma2024,
  author = {Sarma, Shohinee},
  title = {Intensive Glucose Control in Critically Ill Patients — How Low Do We Go?},
  journal = {NEJM Evidence},
  year = {2024},
  doi = {10.1056/evide2400196}
}
Kostenlos starten →